Abstracts tagged "Hepatic disorders"

Abstract Number: 1513 • 2015 ACR/ARHP Annual Meeting
Reactivation of Hepatitis B-Infection in German Patients with Inflammatory Rheumatic Diseases Treated with Biologics – a Monocentric Analysis Involving 1107 Patients
Eva Christina Scharbatke¹, Sonja Kreissl-Kemmer², Hans-Peter Tony³, Marc Schmalzing⁴ and Andreas Geier², ¹Rheumatology/Immunology, University hospital Wuerzburg, Wuerzburg, Germany, ²Hepatology, University hospital Wuerzburg, Wuerzburg, Germany, ³University Hospital Würzburg, Würzburg, Germany, ⁴Rheumatology/Clinical Immunology, University Hospital Würzburg, Würzburg, Germany
Background/Purpose: Hepatitis B virus (HBV) reactivation is a common complication of immunosuppressive treatment in countries with a high prevalence of HBV infection. Biologics – and…
Abstract Number: 2752 • 2014 ACR/ARHP Annual Meeting
Budd-Chiari Syndrome Due to Behçet’s Syndrome: Some Patients Present without Liver Related Symptoms and Have a Better Outcome
Emire Seyahi¹, Erkan Caglar², Serdal Ugurlu¹, Fatih Kantarci³, Vedat Hamuryudan¹, Abdullah Sonsuz⁴, Melike Melikoglu⁵, Sebahattin Yurdakul¹ and Hasan Yazici⁵, ¹Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey, ²Division of Gastroenterology, Department of Internal Medicine, Bakirkoy Research and Training Hospital, Istanbul, Turkey, ³Department of Radiology, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey, ⁴Department of Gastroenterology, Cerrahpasa Medical Faculty of Istanbul Universit, Cerrahpasa Medical Faculty of Istanbul University, Istanbul, Turkey, ⁵Istanbul University, Cerrahpasa Medical Faculty, Rheumatology, Istanbul, Turkey
Background/Purpose Behçet’s syndrome (BS) is a well recognized cause of Budd–Chiari syndrome (BCS), however, information about its clinical characteristics and outcome is limited. We had…
Abstract Number: 1821 • 2012 ACR/ARHP Annual Meeting
Clinical Predictors of Methotrexate-Induced Liver Enzyme Elevation in Patients with Rheumatoid Arthritis in an Electronic Medical Record
Monica Ramirez¹, Bing Lu¹, Michelle A. Frits², Anne H. Fossel³, Katherine P. Liao⁴, Robert M. Plenge⁵, Jonathan S. Coblyn⁶, Nancy A. Shadick⁷ and Elizabeth W. Karlson⁴, ¹Rheumatology, Brigham and Women's Hospital, Boston, MA, ²Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ³Rheumatology/Immunology, Brigham & Womens Hospital, Boston, MA, ⁴Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ⁵Division of Rheumatology, Immunology and Allergy and Division of Genetics, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, ⁶Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ⁷Rheumatology/Immunology, Brigham and Women's Hospital, Boston, MA
Background/Purpose: Methotrexate (MTX) use for the treatment of rheumatoid arthritis (RA) has been associated with hepatotoxicity, and requires monitoring of liver transaminases. However, elevations in…